Mean Tools

Startup Term Sheet Statistics (2026) | STARTUP EDITION

Startup Term Sheet Statistics 2026: 93% of pre-seed rounds skip term sheets for SAFEs. Learn the real Series A norms so you spot bad terms and keep more equity.

Violetta Bonenkamp

—

MEAN CEO - Startup Term Sheet Statistics (2026) | STARTUP EDITION | Startup Idea of the Month News | October

TL;DR: Startup Term Sheet Statistics in 2026 and What They Mean for Your Next Round

Table of Contents

Startup Term Sheet Statistics in 2026 show that you can win a big valuation and still lose the deal. The clauses, not the price, decide what you take home. Violetta Bonenkamp (Mean CEO) compares Carta, Cooley and HSBC data to show you what a fair deal looks like.

  • The headline valuation is the least interesting line on your term sheet. Option pool size and liquidation preferences can quietly move your ownership by 5 to 10 points.
  • The numbers back this up. Carta reports that 93% of pre-seed rounds were SAFEs in Q2 2026, and median Series A dilution fell to 18.7%. Cooley found that 98.2% of deals used a 1x liquidation preference, so treat anything higher as a red flag.
  • The market runs at two speeds. Later rounds look founder-friendly. UK Seed terms are getting tougher, with participating preferences doubling from 7% to 14% (HSBC data).
  • What this means for you: model every SAFE at three Series A valuations and build an exit waterfall. Size your option pool to a real 18-month hiring plan. Run a tight 4-to-6-week raise so investors compete for your round.

Before your first priced round arrives, check your cap table against these founder dilution benchmarks and the latest funding statistics by stage. Then read the full checklist so you keep more of the company you are building.

Check out other fresh news, stats and trends that you might like:

Startup Idea of the Month News | October, 2026 (STARTUP EDITION)

Startup Term Sheet Statistics
When the VC calls it a founder friendly term sheet but the liquidation preference says 3x… time to Google what participating preferred actually means. Unsplash

Startup Term Sheet Statistics for 2026 open with a number that surprises most first-time founders: 93% of all pre-seed rounds in Q2 2026 were structured as SAFEs, according to Carta, and that share climbs to 95% when measured by capital raised. Almost NOBODY signs a real term sheet before their first priced round. Most founders meet liquidation preferences, anti-dilution clauses and board seat negotiations for the FIRST time when the stakes are already in the millions. If you are bootstrapping, building a women-led company, or operating from a smaller European ecosystem, you get even fewer practice rounds than a Silicon Valley founder with a warm investor network.

I am Violetta Bonenkamp, known in the startup world as Mean CEO. I run CADChain, a deeptech company building IP protection for CAD files, and Fe/male Switch, a startup game and incubator for women founders. I run them in parallel, from Europe, with grants, accelerators and investor conversations as part of my regular week. I have sat through programs such as Venture Deals and Investor Readiness training, and I have read enough term sheets to know that the headline valuation is usually the LEAST interesting line on the page.

Here is why these numbers matter right now. Global venture funding hit $425 billion in 2025, up 30% from $328 billion, according to Stripe’s startup statistics roundup. Capital is back, but it is concentrating in fewer, larger, later-stage deals, mostly in AI and DeepTech. If you do not understand what a “normal” term sheet looks like in 2026, you will not know when you are being offered a fair deal, a generous one, or a trap.

Where do these startup term sheet statistics come from?

I care about sources because founders make six- and seven-figure decisions on these numbers. Every statistic in this article comes from published reports, platform data, or law firm surveys released between late 2025 and Q2 2026. I compared them against each other rather than copying one source, and I flag every place where they disagree.

Which sources did I use?

What is the geographic coverage?

Carta and Cooley data lean heavily toward US deals. The HSBC guide is UK-focused. I did not find a comparable, public, term-sheet-level dataset for continental Europe in this research set, which is a gap I discuss later. When I talk about the Netherlands, Germany or other EU markets, I am adding my own operating experience, and I label it as such.

Disclaimer: statistics are DIRECTIONAL, not guarantees. Your sector, traction, founder track record, and the specific investor across the table will move your terms more than any median. Use these numbers as a negotiation compass, and always have a startup lawyer review a term sheet before you sign.

What are the headline startup term sheet statistics for 2026?

Let’s break it down. Here are the numbers I would put on a sticky note above every founder’s desk, each with what it should change in your thinking.

  • Stat: The median Series A in Q2 2026 was priced at a $76.3 MILLION post-money valuation on $14.7 MILLION raised, with founder dilution around 18.7% (Carta).
    • Founder takeaway: dilution is LOWER than at any point in the past few years, so if an investor asks for 25% or more at Series A, ask them to justify it with your specific risk profile.
  • Stat: 93% of pre-seed rounds were SAFEs in Q2 2026, rising to 95% by capital raised (Carta).
    • Founder takeaway: your first “real” term sheet will probably be your Series A, so start studying terms BEFORE you need them.
  • Stat: The down-round rate fell to 11.4% in Q1 2026, from a peak of about 22% in 2023 (Carta).
    • Founder takeaway: roughly 1 in 9 priced rounds is still a down round, so avoid overpricing your current round and creating a trap for the next one.
  • Stat: 98.2% of deals carried a 1x liquidation preference and 96.4% used nonparticipating preferred stock (Cooley, Q1 2026, 165 financings).
    • Founder takeaway: 1x nonparticipating is the DEFAULT, so treat anything above it as a red flag rather than a “standard term”.
  • Stat: Series B and C+ deals rose to 31% of UK term sheets, up from 26% in 2024 (HSBC).
    • Founder takeaway: investors are backing fewer, scaled companies, so early-stage founders compete harder for a smaller slice of attention.
  • Stat: US investors now represent 37% of UK Series C+ capital, up from 27% in 2024 and 23% in 2023 (Guinness Ventures, HSBC data).
    • Founder takeaway: if you are a European company planning to scale, your growth-stage lead investor may very well be American, with American term sheet habits.
  • Stat: 65% of UK Series B and C+ rounds were led by foreign investors, representing £5.9bn (Disruption Banking, HSBC data).
    • Founder takeaway: build cross-border investor relationships two years before you need the money.
  • Stat: Participating preferences in UK Seed rounds doubled from 7% to 14% (Guinness Ventures).
    • Founder takeaway: Seed terms are getting TOUGHER even as later-stage terms get softer, so do not assume the founder-friendly headlines apply to you.
  • Stat: 78% of surveyed VCs show conviction in AI and 71% in DeepTech (HSBC investor pulse via Guinness Ventures).
    • Founder takeaway: if your company is neither, your story must explain why you still deserve a term sheet in a market chasing two themes.
  • Stat: 53% of investors expect founders to push for more aggressive valuations, while 71% expect term structures to stay broadly unchanged (Guinness Ventures).
    • Founder takeaway: you may win on price, but expect investors to hold the line on structure, so negotiate the clauses, not only the number.

Stat 1: What does a typical Series A term sheet look like in 2026?

The numbers

  • Median Series A post-money valuation in Q2 2026: $76.3 million (Carta).
  • Median amount raised: $14.7 million (Carta).
  • Median founder dilution: about 18.7%, lower than at any point in the past few years (Carta).
  • SeedScope estimates median US Series A pre-money valuations at roughly $35 to $45 million, down from $55 to $65 million peaks in 2021 and up from $25 to $30 million troughs in 2023.

Quick definitions

A term sheet is a mostly non-binding document that sets out the price and conditions of an investment in a priced round, where investors buy preferred stock at a specific price per share. Pre-money valuation is what the company is worth before the new money comes in. Post-money valuation is pre-money plus the new investment. Dilution is the percentage of ownership existing shareholders give up in the round.

My interpretation

Do the math on Carta’s medians and you get an implied pre-money of roughly $61.6 million ($76.3M minus $14.7M). That is far above SeedScope’s $35 to $45 million range. I explain the gap in the data inconsistency section, but the short version is this: a small group of AI-heavy, high-traction companies pull platform medians up. If you are a European B2B SaaS company with €1 million in annual recurring revenue, the Carta median is probably NOT your benchmark.

The dilution figure matters more to me than the valuation. Here is a simple example. Say two co-founders together own 60% after a Seed round. If they give up 18.7% at Series A, they drop to about 48.8% combined. Give up 25% instead, and they land at 45%. That 3.8-point difference looks small on a slide, but at a €200 million exit it equals €7.6 million in founder value.

Then there is the option pool shuffle, the clause I see founders miss most often. SeedScope gives a clear example: on a $20 million pre-money with a 15% option pool created pre-money, the effective pre-money to existing shareholders drops to roughly $17 million. Changing pool size or timing can shift founder ownership by 5 to 10 percentage points. The headline valuation stays pretty. Your share of the pie quietly shrinks.

Bootstrapped vs VC-funded founders

A bootstrapped founder who raises a first priced round late, with revenue, usually has MORE negotiating power than a founder who has burned through two SAFEs and needs cash in 60 days. VC-funded founders often accept a bigger option pool because the next hire plan is already on the table. Bootstrappers can argue for a smaller pool sized to a real 18-month hiring plan, not a generic 15% to 20%.

Moves for the next 90 days

  1. Build a dilution model now. Because the median Series A dilution sits at 18.7%, model three scenarios (15%, 18.7%, 25%) for your cap table so you know your walk-away number before any meeting.
  2. Write a hiring plan to size your option pool. Because pool size can move your ownership by 5 to 10 points, list every hire for the next 18 months with an equity grant estimate, then use that total in negotiation.
  3. Find your real comparables. Ask three founders in your sector and country what their Series A looked like, since platform medians blend AI megadeals with ordinary companies.

Stat 2: Why do 93% of pre-seed rounds skip the term sheet entirely?

The numbers

  • 93% of pre-seed rounds in Q2 2026 were structured as SAFEs (Carta).
  • 95% of pre-seed capital went through SAFEs (Carta).
  • Carta notes term sheets “may be used during a seed round, but they are more common at the Series A round and beyond”.

What is a SAFE?

A SAFE (Simple Agreement for Future Equity) is a short contract, introduced by Y Combinator, where an investor gives you money now in exchange for the right to receive shares later, usually at your next priced round. It typically includes a valuation cap (the maximum valuation at which the money converts) and sometimes a discount. There is no board seat negotiation, no price per share set today, and very little legal cost.

My interpretation

SAFEs are fast and cheap, and I like fast and cheap at the earliest stage. But here is the provocative part: SAFEs postpone the dilution conversation, they do not cancel it. I regularly meet founders who have stacked three or four SAFEs with different caps and have NO idea how much of their company they will own after conversion. That surprise lands at the Series A table, exactly when you can least afford a shock.

For European founders, there is another twist. The SAFE is a US instrument. In the UK, many founders use advance subscription agreements to stay compatible with SEIS and EIS tax relief schemes. In the Netherlands and Germany, convertible loan agreements are common. Each instrument has different tax, interest and conversion mechanics. Copying a US SAFE template into a Dutch BV without legal review is a classic mistake.

Solo founders and SAFEs

If you are a solopreneur, you are also the CFO. That means the cap table spreadsheet is your job. I treat every SAFE like a future term sheet: I calculate its conversion at three possible Series A valuations the same day I sign it. At Fe/male Switch, I built this exact exercise into the game as a quest, because founders learn dilution faster when they watch their own simulated ownership shrink.

Moves for the next 90 days

  1. Run a conversion model on every convertible instrument you hold. Because 95% of pre-seed capital sits in SAFEs, your future ownership depends on numbers you have not calculated yet.
  2. Standardize your caps. Avoid giving each angel a different cap and discount; it complicates conversion and annoys your Series A lead.
  3. Check the local instrument. Ask a lawyer in your jurisdiction whether a SAFE, an advance subscription agreement, or a convertible loan fits your tax setup and investor base.

Stat 3: Are term sheets founder-friendly in 2026?

The numbers

  • 98.2% of deals in Cooley’s Q1 2026 report carried a 1x liquidation preference.
  • 96.4% used nonparticipating preferred stock (Cooley).
  • The down-round rate fell to 11.4% in Q1 2026, from about 22% in 2023 (Carta).
  • Carta reports liquidation preferences and participation rights near multi-year lows.
  • In the UK, participating preferences at Seed doubled from 7% to 14% (Guinness Ventures).

Liquidation preference, explained with numbers

A liquidation preference decides who gets paid first, and how much, when the company is sold or wound down. Imagine an investor puts in €10 million for 20% of your company, and you sell for €30 million.

  • 1x nonparticipating: the investor picks the better of €10 million back OR 20% of €30 million (€6 million). They take €10 million. Founders and others share €20 million.
  • 1x participating: the investor takes €10 million first AND 20% of the remaining €20 million (€4 million), for €14 million total. Everyone else shares €16 million.
  • 2x nonparticipating: the investor takes €20 million off the top. Everyone else shares €10 million.

Same exit, same valuation, wildly different outcomes. That is why I tell founders to read the waterfall before they celebrate the headline.

Anti-dilution: the clause with a dangerous version

Anti-dilution provisions protect investors if a future round is priced lower than theirs (a down round). The common, reasonable version is broad-based weighted average, which adjusts the investor’s conversion price partially, based on how much new money comes in and at what price. The harsh version is full ratchet, which resets the investor’s price all the way down to the new, lower price, no matter how small the down round. Carta notes that aggressive anti-dilution and participating-preferred terms are rarer than a few years ago, giving founders more room to hold the line.

My interpretation: the two-speed market

The headlines say “founder-friendly”. The UK Seed data says the opposite. Participating preferences at Seed doubled, syndication is rising, and investors want more performance before they write cheques. Guinness Ventures puts it bluntly: “The easy Seed rounds of 2021 era are long gone for the vast majority of companies outside a small number of sectors, primarily parts of the AI and defence ecosystems.”

My reading: the market is founder-friendly for founders who already have leverage-free strength, meaning traction, competition between investors, and a hot sector. For everyone else, especially small Seed rounds under £2 million, terms are getting tighter. Women founders and founders outside capital cities often sit in that second group, not because of weaker companies but because of thinner investor networks that produce fewer competing offers.

Moves for the next 90 days

  1. Memorize the default. Because 98.2% of deals use 1x and 96.4% are nonparticipating, write “1x nonparticipating, broad-based weighted average anti-dilution” at the top of your negotiation notes as your baseline.
  2. Build an exit waterfall spreadsheet. Model payouts at three exit values (low, base, high) for every term sheet you receive, so you compare offers on what founders actually take home.
  3. Create competition early. Because UK Seed terms are tightening, run a compressed fundraising process with 20 to 30 qualified investors in a four-to-six-week window instead of drip-feeding meetings over six months.

Stat 4: Why is late-stage money coming back, and who is writing the cheques?

The numbers

  • Series B and C+ activity reached 31% of all UK term sheets, up from 26% in 2024 (HSBC).
  • UK investors lead at Seed with about 70% of term sheets and anchor Series A at about 54% (Guinness Ventures).
  • US investors represent 37% of UK Series C+ capital, up from 27% in 2024 and 23% in 2023.
  • 65% of UK Series B and C+ rounds were led by foreign investors, representing £5.9bn (Disruption Banking).
  • £3.1bn of the £5.9bn in inbound capital in 2025 came from the US (Guinness Ventures).

My interpretation: Europe builds, America scales

HSBC calls the late-stage rebound a “flight to quality , with capital focused on fewer, scaled companies, leading to higher valuations, less deal structuring and more founder friendly terms.” Guinness Ventures calls it the “UK scale-up gap made visible in data”. I would extend that to most of continental Europe. We build companies well at the early stage, then hand them to American capital at the growth stage.

This is not automatically bad. US investors bring larger cheques and global networks. But it changes your term sheet. US growth investors may push for a Delaware flip, US-style governance, and different expectations around board composition and exits. If you build a European company with European grants (as I have with CADChain), you need to check how a later US-led round interacts with grant conditions, IP ownership rules and local tax incentives. I have seen founders discover these conflicts during due diligence, which is the most expensive possible moment.

Bootstrapped founders and the scale-up gap

Here is the contrarian angle. If late-stage capital concentrates in “fewer, scaled companies”, a profitable bootstrapped business with real revenue fits the “quality” profile investors now chase. Some of the best term sheets I have seen went to founders who did not need the money. Bootstrapping is a negotiation strategy as much as a funding strategy.

Moves for the next 90 days

  1. Map your future lead investors by geography. Because 65% of UK Series B and C+ rounds are led by foreign investors, list ten US and pan-European growth funds in your sector and start sending quarterly updates now.
  2. Audit your structure for a cross-border round. Check whether your grants, IP assignments and shareholder agreements would survive a US-led round or a holding company flip.
  3. Track “quality” metrics investors pay for. Pick three numbers (net revenue retention, gross margin, months of runway) and report them monthly, since late-stage capital rewards proven scale.

Stat 5: Which sectors get the term sheets in 2026?

The numbers

  • AI (generative and LLMs) remains the dominant investment theme (HSBC).
  • DeepTech activity reached 35% of UK deals, up from 15% in 2021, across cybersecurity, energy, HardTech and CleanTech (HSBC).
  • Investor conviction: AI 78%, DeepTech 71% (Guinness Ventures).
  • Outside London, CleanTech (61%) and Life Sciences (60%) power deal activity (Disruption Banking).
  • 71% of VCs are optimistic about 2026, and 41% prioritise new investments, up from 20% in 2025 (Guinness Ventures).

My interpretation from the deeptech trenches

I run a deeptech company, so I should be cheering. Partly, I am. HSBC links the DeepTech rise to a preference for businesses with strong competitive moats and the strategic importance of sovereign tech capabilities. That matches what I see in European policy conversations, including my work around the OECD Global Blockchain Policy Forum, where CADChain was one of 12 startups selected globally.

But DeepTech term sheets carry their own quirks. Longer development cycles mean more milestone-based tranches, more scrutiny of IP ownership, and more questions about who owns code written under a grant. If your IP is messy, your valuation drops, no matter how hot the sector. At CADChain we treat IP protection as a technical layer inside the product, and I apply the same logic to fundraising: clean IP is a term sheet asset.

And if you are not in AI or DeepTech? Then your term sheet case depends on proof. Revenue, retention and capital discipline become your sector story. A non-AI company with paying customers often negotiates better than an AI company with a demo and a waitlist, once the investor does proper diligence.

Moves for the next 90 days

  1. Clean up your IP chain. Because DeepTech now accounts for 35% of UK deals and investors pay for moats, confirm that every founder, employee and contractor has signed an IP assignment.
  2. Describe your moat in one sentence. Investors with 71% conviction in DeepTech will ask what stops a competitor from copying you; answer with patents, data, workflow lock-in or regulation.
  3. Look beyond the capital city. Because CleanTech and Life Sciences dominate regional deal activity, regional funds and grant-matched programs may give you better terms than the crowded central market.

Quotable insights and predictions on term sheets

Journalists, newsletter writers and fellow founders: feel free to quote these, with attribution to Violetta Bonenkamp (Mean CEO). Each prediction is an extrapolation from the statistics above, not a certainty.

  • “By 2027, founders who model SAFE conversion at three valuations before signing will negotiate Series A dilution closer to the 18.7% median, because 95% of pre-seed capital now sits in instruments most founders never calculate.”
  • “In 2026, the headline valuation is the least interesting line on a term sheet. With 98.2% of deals at 1x liquidation preference, the real fight has moved to option pool size, which can shift founder ownership by 5 to 10 points.”
  • “Europe builds startups and America scales them. US investors went from 23% to 37% of UK Series C+ capital in two years, and by 2027 European founders without a US investor relationship will face a smaller pool of growth-stage leads.”
  • “The term sheet market of 2026 runs at two speeds: founder-friendly at Series B and later, tougher at Seed, where participating preferences doubled from 7% to 14%.”
  • “A profitable bootstrapped company is the ‘quality’ asset that a flight-to-quality market is searching for. By 2027, founders who delay their first priced round until they have revenue will negotiate cleaner terms than those who raise on a pitch deck.”
  • “When 53% of investors expect founders to push valuations and 71% expect structures to stay put, founders should trade price for cleaner terms, never the other way around.”

Where is term sheet data inconsistent or missing?

Honest analysis means admitting what the numbers do NOT tell us. Here are the gaps and contradictions I found.

Inconsistency 1: Series A valuations do not match

Carta’s median post-money of $76.3 million on $14.7 million raised implies a pre-money near $61.6 million. SeedScope places the median US Series A pre-money at $35 to $45 million. Possible reasons: Carta measures companies on its own platform in a single quarter, which can be pulled up by AI megadeals; SeedScope offers a broader market estimate; and medians of post-money and amount raised cannot simply be subtracted to get a median pre-money. Also, Carta’s median dilution of 18.7% differs from the simple ratio of the two medians (about 19.3%), which is a reminder that medians come from different deals.

Inconsistency 2: “Founder-friendly” depends on where you look

Cooley shows 96.4% nonparticipating preferred in a US sample of 165 financings. The UK Seed data shows participating preferences at 14%. These are different stages, countries and sample sizes (165 financings vs 711 term sheets), so both can be true at once. Founders should benchmark against their own stage and geography.

Under-researched: what nobody is measuring

  • Gender: none of these term sheet datasets break down terms by founder gender. We know women founders face structural barriers in access to capital and networks, but we do not know whether they receive different liquidation preferences, option pool demands or board terms. That is a research gap worth funding.
  • Continental Europe: there is detailed UK and US data, but no comparable public dataset for the Netherlands, Germany, France, the Nordics or Central and Eastern Europe in this research set.
  • Bootstrapped founders: reports rarely separate companies that raised a first priced round after years of profitable growth from those that raised on a plan.
  • Solo founders: there is almost no data on how investors price single-founder companies vs teams at term sheet stage.
  • Grant-backed companies: European startups often combine EU or national grants with equity, but term sheet reports do not track how grant obligations affect terms.

Minor factors that can change the picture

  • Tax regimes: SEIS and EIS in the UK shape which instruments founders use, and similar local incentives exist across EU states.
  • Corporate law: notary requirements for share issuance in countries such as the Netherlands and Germany add cost and time to priced rounds, which partly explains why convertibles stay popular.
  • Currency: mixing pound, euro and dollar figures distorts comparisons, especially when exchange rates move.
  • Ecosystem maturity: founders in smaller hubs see fewer competing term sheets, which weakens their negotiating position regardless of company quality.

How should different founders use these term sheet numbers?

Bootstrapping founders

  • Stats to watch: late-stage share at 31% of term sheets; down-round rate at 11.4%; 1x nonparticipating as the default.
  • Move 1: delay your first priced round until revenue gives you options. Investors chasing quality pay for proof.
  • Move 2: set your valuation sensibly. A round priced too high raises your odds of joining the 11.4% who face a down round and its anti-dilution consequences.
  • Move 3: reject any liquidation preference above 1x. With 98.2% of deals at 1x, you have the data on your side.

Women-led startups

  • Stats to watch: UK Seed participating preferences doubled to 14%; Seed rounds becoming more investor friendly; no gender data in term sheet reports.
  • Move 1: practise negotiation in low-risk settings before the real round. I built Fe/male Switch as exactly that kind of sandbox, because women do not need more inspiration; they need infrastructure.
  • Move 2: generate competing offers. Network gaps produce fewer term sheets, and a single offer is a weak position. Run a tight, parallel process.
  • Move 3: track your own terms and share them anonymously with founder communities. Until reports segment by gender, we have to build the dataset ourselves.

Solopreneurs and solo founders

  • Stats to watch: 93% of pre-seed rounds are SAFEs; option pool shuffles can move ownership by 5 to 10 points.
  • Move 1: use AI tools as your fundraising back office. Let them draft cap table models, summarize term sheets and compare clauses, while you keep the judgment calls.
  • Move 2: budget for a good startup lawyer. When you are the CEO, CFO and head of sales at once, one hour of expert review protects more value than ten hours of your own reading.
  • Move 3: negotiate the option pool down to a documented hiring plan, since solo founders often need fewer immediate hires than investors assume.

EU startups

  • Stats to watch: US investors at 37% of UK Series C+ capital; 65% of UK late-stage rounds led by foreign investors; DeepTech at 35% of UK deals.
  • Move 1: stack non-dilutive money first. National and EU grants and accelerator programs (CADChain has benefited from several) extend runway and raise your valuation before the first priced round.
  • Move 2: choose the right local instrument (SAFE, advance subscription agreement, or convertible loan) with a lawyer who knows your jurisdiction.
  • Move 3: start US investor relationships at Series A, not Series C. The data says they will likely lead your growth round anyway.

What term sheet mistakes should founders avoid in 2026?

  • Negotiating valuation in isolation. SeedScope warns that a higher headline number can hide terms that cost you more than the valuation gains.
  • Accepting a pre-money option pool without math. A 15% pool on a $20 million pre-money cuts your effective pre-money to about $17 million.
  • Calling participating preferred “standard”. Only 3.6% of Cooley’s Q1 2026 deals used it. It is the exception.
  • Agreeing to full ratchet anti-dilution. Broad-based weighted average is the market norm.
  • Stacking SAFEs with random caps. It creates conversion chaos at Series A.
  • Ignoring the investor as a person. As First Citizens notes, even the most favorable terms cannot compensate for a poor investor partnership.
  • Skipping legal review. Carta’s advice is clear: have a lawyer review the term sheet before you sign.

Frequently asked questions about startup term sheets in 2026

What is the median Series A valuation in 2026?

According to Carta, the median Series A in Q2 2026 was priced at a $76.3 million post-money valuation on $14.7 million raised. SeedScope estimates median US Series A pre-money valuations at $35 to $45 million, so your benchmark depends heavily on sector and traction.

How much equity do founders give up at Series A?

Median founder dilution at Series A was about 18.7% in Q2 2026, per Carta, lower than at any point in the past few years. Option pool expansions can add another 5 to 10 points of effective dilution if created pre-money.

Is a SAFE the same as a term sheet?

No. A SAFE is a convertible instrument that delays pricing until a later round, while a term sheet sets the price and conditions of a priced equity round. In Q2 2026, 93% of pre-seed rounds used SAFEs instead of term sheets.

What is a standard liquidation preference in 2026?

The market standard is 1x nonparticipating. Cooley’s Q1 2026 report found 98.2% of deals used a 1x preference and 96.4% used nonparticipating preferred stock.

How common are down rounds in 2026?

Carta reports a down-round rate of 11.4% in Q1 2026, down from a peak of about 22% in 2023. That means roughly 1 in 9 priced rounds still happens at a lower valuation than the previous round.

What should you do next? A practical term sheet checklist

Next steps. Statistics are useless unless they change a decision. Here is the checklist I would give any founder in my network this quarter.

  1. Pick two statistics from this article that contradict your current assumptions. Maybe you thought participating preferred was normal, or that 25% dilution at Series A was standard.
  2. Build or update your cap table model with every SAFE, convertible loan and option grant, then run conversion at three Series A valuations.
  3. Write your baseline terms: 1x nonparticipating, broad-based weighted average anti-dilution, option pool sized to a real hiring plan.
  4. Build an exit waterfall to compare any term sheet on founder take-home value, not headline valuation.
  5. List 20 to 30 target investors, including at least five foreign or US funds if you plan to scale past Series B.
  6. Book a lawyer who knows startup financings in your jurisdiction before the first term sheet arrives.
  7. Set one metric (months of runway, net revenue retention, or monthly revenue) and track it for 90 days, because investors chasing quality ask for proof.

The Mean CEO framework: Observe, Interpret, Act, Adapt

  • Observe: collect term sheet statistics for your stage, geography and sector, and separate US, UK and continental EU data.
  • Interpret: translate each number into consequences for your ownership, runway and next round. A 1x preference and a 2x preference are not “details”.
  • Act: change one thing in your fundraising plan, such as resizing the option pool or switching your convertible instrument, and measure its effect.
  • Adapt: revisit your playbook every quarter, since Carta, HSBC and Cooley update their numbers regularly and the market moves fast.

I treat fundraising the way I treat game design: it is a system of incentives, rules and hidden mechanics. Founders who learn the rules before they play, ideally in a setting where mistakes are cheap, keep more of their company and pick better partners. The 2026 data shows a market that rewards prepared, proven founders and quietly punishes everyone who walks in with only a pitch deck and a hopeful smile. Read the whole term sheet. Model the waterfall. Bring competition to the table. And never sign the first draft.

FAQ on Startup Term Sheet Statistics and Negotiation in 2026

How much of the company do founders typically still own after Series B?

Carta data shows founding teams hold about 56% fully diluted after Seed, 36% after Series A and roughly 23% after Series B. Model dilution across every round, not one round at a time, and push back on oversized pools. The median Seed employee pool is 12.1%. Compare female founder dilution benchmarks

Which non-economic term sheet clauses deserve as much attention as valuation?

Board composition, protective provisions (investor vetoes), drag-along rights, pro rata rights and information rights shape control long after the money lands. Aim for a founder-majority or balanced board at Series A. Limit veto lists to genuinely major decisions, such as selling the company. Read First Citizens' guide to reading a startup term sheet

What happens after you sign a startup term sheet?

Signing usually starts an exclusivity or no-shop period. Then come legal and financial due diligence and the drafting of definitive documents, such as the share purchase and shareholders' agreements. Prepare a data room before signing, because messy IP, cap tables or contracts can delay closing or reopen terms. See Carta's term sheet guide for startups

Where can founders find a clean, founder-friendly term sheet template?

Carta worked with Gunderson Dettmer on a fair sample term sheet, and Visible publishes a template covering the six core components. Use one as your benchmark. Highlight every clause in an investor's draft that deviates from it, then ask your lawyer which deviations matter. Get Visible's VC term sheet template

Should a startup take a bridge round instead of a new priced round?

Bridge rounds grew to 16.6% of venture cash in Q2 2025, so they are common, not shameful. Take one only if it funds a clear milestone that raises your next valuation. Otherwise you stack convertibles and risk joining the down-round statistics. Explore startup funding statistics by stage

How should founders evaluate a venture debt term sheet?

Look past the headline rate, because European venture debt often costs closer to 13% plus warrants. Shorter terms also raise monthly repayments: a 24-month loan costs about 42% more per month than a 36-month loan of the same size. Negotiate covenants, warrant coverage and interest-only periods before signing. Read European venture debt statistics

What funding alternatives exist for women founders who lack competing term sheets?

Women run 28% of firms but receive just 16% of loan dollars, and 62% of struggling firms lean on personal funds. Before accepting a weak single offer, combine grants, revenue and targeted borrowing. Borrow only for expenses with a clear payback date, and back the plan with a 13-week cash flow forecast. Review women entrepreneur credit access statistics

Does building an AI startup improve term sheet odds for female founders?

Largely, yes: AI-focused ventures captured two-thirds of VC funding for female founders in 2025. However, investors now discount generic AI wrappers. Prove a moat through proprietary data, distribution or domain depth before your first priced round to avoid tougher terms. See 2026 startup statistics on AI and funding

Why do EIS and VCT funds matter for UK founders negotiating early rounds?

UK investors lead about 70% of Seed and 54% of Series A term sheets, and EIS and VCT funds are a key part of that domestic capital. Protect your EIS eligibility before signing. Shares carrying preferential liquidation rights can jeopardise the tax relief and shrink your domestic investor pool. Read Guinness Ventures' analysis of the 2026 term sheet guide

How do option pools work for European startups where stock options are complicated?

Many continental founders use alternatives to US-style options, such as virtual (phantom) share plans, common in Germany, or Dutch STAK certificate structures. Clarify in the term sheet whether the pool is real or virtual, how it dilutes, and who bears notary and tax costs. Explore the European Startup Playbook

People Also Ask:

What is a startup term sheet?

A startup term sheet is a short document that summarizes the proposed terms of an investment in a company. It lays out the conditions between the founders and the investors, such as the amount being invested, the company's valuation, and the rights investors will receive. Lawyers use it as the blueprint for drafting the final, longer legal agreements.

Is a term sheet legally binding?

A term sheet is mostly non-binding. The economic and control terms, such as valuation and board seats, are usually not enforceable until the final agreements are signed. A few clauses are often binding, including confidentiality, exclusivity (also called "no-shop"), and sometimes provisions about who pays legal fees.

What terms are included in a startup term sheet?

Most startup term sheets cover the following:

  • Valuation and price per share: Often stated as a pre-money valuation, from which the share price is calculated.
  • Investment amount: How much capital the investor will put in.
  • Liquidation preference: Who gets paid first, and how much, if the company is sold or shut down.
  • Board composition: How many seats founders and investors will hold.
  • Voting and protective rights: Decisions that need investor approval.
  • Anti-dilution protection: How investors are protected if future rounds happen at a lower price.
  • Founder vesting and option pool: How founder shares vest and how much equity is set aside for future employees.

How much equity do startups give away in a term sheet?

SeedLegals data shows that startups commonly give away about 15% of their equity in each funding round. The exact amount depends on the stage, the size of the raise, and the company's traction. Seed rounds often fall in the 10% to 25% range, and founders usually aim to raise enough money to reach their next major goal before giving up more ownership.

What is the most common liquidation preference in startup term sheets?

A 1x non-participating liquidation preference is the market standard. Cooley data covering 238 venture financings found that 98% of deals in Q2 2025 used a 1x liquidation preference. This means investors get back their original investment before common shareholders are paid, but they do not collect a multiple of that amount.

What is the most common anti-dilution provision in term sheets?

Broad-based weighted average anti-dilution is the most common form seen in venture deals. It adjusts the investor's conversion price if the company later raises money at a lower valuation, but it does so in a way that is fairer to founders than "full ratchet" protection, which is rare in current deals.

What percentage of term sheets actually close?

Industry estimates vary, but most signed term sheets do go on to close, with figures commonly cited in the range of 70% to 90%. Deals can still fall apart during due diligence if investors find problems with the company's finances, legal standing, or cap table, or if market conditions shift before the final documents are signed.

How long does it take to close a deal after signing a term sheet?

Closing usually takes about 30 to 60 days after a term sheet is signed. During this time, investors complete due diligence and lawyers draft the final agreements. Many term sheets include a no-shop clause for a similar period, which prevents the founders from seeking other investors while the deal is being finalized.

Where can I find reliable startup term sheet statistics?

Good sources of term sheet data include Carta, which publishes reports based on cap table and funding data, and law firms such as Cooley and Fenwick, which release regular reports on venture financing terms. The PitchBook-NVCA Venture Monitor and SeedLegals also publish data on valuations, deal sizes, and common terms in startup rounds.

How should founders read and negotiate a term sheet?

Hustle Fund suggests reading a term sheet in three passes: economics, control, and deal structure. This approach stops a favorable headline valuation from hiding unfavorable terms elsewhere in the document. Founders should compare each clause against market standards, focus negotiations on the terms that matter most to long-term ownership and control, and work with an experienced startup lawyer before signing.

MEAN CEO - Startup Term Sheet Statistics (2026) | STARTUP EDITION | Startup Idea of the Month News | October

Violetta Bonenkamp, also known as Mean CEO, is a female entrepreneur and an experienced startup founder, bootstrapping her startups. She has an impressive educational background including an MBA and four other higher education degrees. She has over 20 years of work experience across multiple countries, including 10 years as a solopreneur and serial entrepreneur. Throughout her startup experience she has applied for multiple startup grants at the EU level, in the Netherlands and Malta, and her startups received quite a few of those. She’s been living, studying and working in many countries around the globe and her extensive multicultural experience has influenced her immensely. Constantly learning new things, like AI, SEO, zero code, code, etc. and scaling her businesses through smart systems.